ChoA Pharmaceutical Co.Ltd (034940) — Working Capital to Net Assets Ratio
ChoA Pharmaceutical Co.Ltd (034940) has a Working Capital to Net Assets ratio of 12.7% as of March 2026. Working capital of ₩2.76 Billion (current assets of ₩35.71 Billion minus current liabilities of ₩32.96 Billion) is measured against net assets of ₩21.62 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 034940 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ChoA Pharmaceutical Co.Ltd Working Capital to Net Assets (2014–2025)
This chart shows how ChoA Pharmaceutical Co.Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 12.7%, reflecting working capital of ₩2.76 Billion against net assets of ₩21.62 Billion KRW. See how many days can ChoA Pharmaceutical Co.Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for ChoA Pharmaceutical Co.Ltd (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ChoA Pharmaceutical Co.Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see ChoA Pharmaceutical Co.Ltd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -3.3% | ₩-707.59 Million | ₩21.77 Billion | ₩35.05 Billion | ₩35.76 Billion | ▼ -13.1 pp |
| 2024 | 9.8% | ₩3.08 Billion | ₩31.38 Billion | ₩39.74 Billion | ₩36.66 Billion | ▼ -23.7 pp |
| 2023 | 33.5% | ₩12.98 Billion | ₩38.76 Billion | ₩42.16 Billion | ₩29.18 Billion | ▼ -6.0 pp |
| 2022 | 39.5% | ₩20.87 Billion | ₩52.84 Billion | ₩48.20 Billion | ₩27.33 Billion | ▼ -5.1 pp |
| 2021 | 44.6% | ₩22.24 Billion | ₩49.92 Billion | ₩46.50 Billion | ₩24.26 Billion | ▼ -3.8 pp |
| 2020 | 48.3% | ₩28.17 Billion | ₩58.30 Billion | ₩47.35 Billion | ₩19.18 Billion | ▼ -9.0 pp |
| 2019 | 57.3% | ₩30.42 Billion | ₩53.06 Billion | ₩53.80 Billion | ₩23.38 Billion | ▲ +3.4 pp |
| 2018 | 53.9% | ₩29.11 Billion | ₩53.96 Billion | ₩53.44 Billion | ₩24.33 Billion | ▼ -13.0 pp |
| 2017 | 66.9% | ₩36.25 Billion | ₩54.18 Billion | ₩52.75 Billion | ₩16.50 Billion | ▲ +23.7 pp |
| 2016 | 43.2% | ₩20.66 Billion | ₩47.84 Billion | ₩44.73 Billion | ₩24.07 Billion | ▼ -1.2 pp |
| 2015 | 44.3% | ₩20.91 Billion | ₩47.15 Billion | ₩41.76 Billion | ₩20.85 Billion | ▼ -4.7 pp |
| 2014 | 49.0% | ₩22.59 Billion | ₩46.09 Billion | ₩41.91 Billion | ₩19.32 Billion | — |